Several fallacies in the TSH-T4 paradigm of thyroid therapy

When you are steeped in a medical paradigm, its fallacies can be as comfortable and taken for granted as an old pair of sneakers. In this post, I'll take apart several thyroid therapy fallacies, starting with the fallacy "description is not prescription." I will investigate many of the ways in which patients on T4 monotherapy …

Continue reading Several fallacies in the TSH-T4 paradigm of thyroid therapy

2014 ATA therapy guidelines: 5. Research

This post continues my series of paraphrases of Jonklaas et al's 2014 guidelines that I left unfinished weeks ago. Here I provide paraphrases and quotations of what they set forth for the "ethics" of research in thyroid therapy in Section 18, and what they recommend as topics for future research in thyroid therapy. I provide …

Continue reading 2014 ATA therapy guidelines: 5. Research

Subclinical hypothyroidism guidelines delay (in)effective therapy

This week, a BBC news article is circulating with the report that "Thyroid disease [is] being over-treated." (May 15, 2019). (1) More specifically, it reported that newly published guidelines claim that "almost all adults with mild or "subclinical" hypothyroidism will not benefit from hormone treatment." In response, thyroid-treated persons who suffer poorly optimized thyroid hormone …

Continue reading Subclinical hypothyroidism guidelines delay (in)effective therapy

2014 ATA Therapy guidelines: 4. Using Synthetic T3

This post continues my paraphrase of Jonklaas et al's 2014 "Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement." As I've explained in my previous post, I've decided not to let my summaries of ATA statements be an uninterrupted series of self-justifications and defenses. I've decided …

Continue reading 2014 ATA Therapy guidelines: 4. Using Synthetic T3

2014 ATA Therapy guidelines: 3. Desiccated thyroid

If we want to disagree with the American Thyroid Association's prejudice against animal sources of thyroid hormone, we should to at least prove we're trying to listen to them. Then we should fairly point out what they didn't say, what truths they would rather not admit, and where they are being unfair or inconsistent. This post …

Continue reading 2014 ATA Therapy guidelines: 3. Desiccated thyroid

2014 ATA Thyroid therapy guidelines: 2. Ethics

Here I move on to part 2 of my summary of ATA thyroid therapy guidelines, where they try to defend the ethics their own stance (Jonklaas et al, 2014). Their self-righteous, defensive and arrogant reply to question 11 deserves its own post. ("WE" = Endocrinologists and other doctors who treat hypothyroidism. Anything in quotation marks is directly …

Continue reading 2014 ATA Thyroid therapy guidelines: 2. Ethics

2014 ATA thyroid therapy guidelines: 1. Levothyroxine

In this series of posts, I paraphrase a 2014 thyroid therapy guidelines document in a way that even the brain-fogged hypothyroid patient can understand more quickly and easily than reading the original version. MY SUMMARY'S AIMS AND METHODS Every thyroid patient understand the basics about what is being said about their therapy by the American …

Continue reading 2014 ATA thyroid therapy guidelines: 1. Levothyroxine